We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mutation Causes Death of Motor Neurons in ALS

By Biotechdaily staff writers
Posted on 17 Mar 2008
Researchers in the field of neurodegenerative disorders have identified a gene linked to both the familial and sporadic forms of amyotrophic lateral sclerosis (ALS).

ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. More...
The progressive degeneration of motor neurons in ALS eventually leads to their death. Lack of motor neurons causes the brain to lose the ability to initiate and control muscle movement, leading to progressive paralysis. On the molecular level, the disorder is characterized by ubiquitinated TAR DNA binding protein (TDP-43) inclusions. TDP-43 had been previously identified as a major component of the protein inclusions found in ALS patients' motor neurons.

Investigators at King's College (London, UK) compared gene maps of ALS patients with those of a large number of normal individuals. They reported in the February 28, 2008, online edition of the journal Science that there were single base mutations in the TDP-43 gene in five affected members of one family, compared to none in unaffected members. They also found mutations in two ALS patients with no family history of the disease (sporadic ALS). No mutations were found in 1,262 unaffected controls or in 523 other ALS cases. In all, three mutations were found, all affecting one region of the protein. In the familial case, the mutation was inherited in an autosomal dominant fashion (one mutant copy was sufficient to cause the disease).

In a second report published in the February 20, 2008, online edition of the Annals of Neurology the investigators presented additional evidence of a direct link between altered TDP-43 function and neurodegeneration.

"The identification of TDP-43 gene mutations in ALS places TDP-43 protein at center stage as a potential cause of motor neuron degeneration. Critically, these mutations will give scientists around the world a new tool to explore the disease process and hopefully accelerate drug discovery,” said senior author Dr. Christopher Shaw, professor of clinical neuroscience at King's College.


Related Links:
King's College

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.